Wu, L., Wu, Y., Chen, R., Liu, Y., Huang, L., Lou, L., . . . Xu, J. (2014). Curcumin derivative C817 inhibits proliferation of imatinib-resistant chronic myeloid leukemia cells with wild-type or mutant Bcr-Abl in vitro. Acta Pharmacol Sin.
Citação norma ChicagoWu, Li-xian, Ying Wu, Rui-jia Chen, Yang Liu, Li-sen Huang, Li-guang Lou, Zhi-hong Zheng, Yuan-zhong Chen, e Jian-hua Xu. "Curcumin Derivative C817 Inhibits Proliferation of Imatinib-resistant Chronic Myeloid Leukemia Cells With Wild-type or Mutant Bcr-Abl in Vitro." Acta Pharmacol Sin 2014.
Citação norma MLAWu, Li-xian, et al. "Curcumin Derivative C817 Inhibits Proliferation of Imatinib-resistant Chronic Myeloid Leukemia Cells With Wild-type or Mutant Bcr-Abl in Vitro." Acta Pharmacol Sin 2014.